Evidence map›Paper›PMID 41514992›Full record

ReviewPlants (Basel, Switzerland)2025

Nano-Elicitation Approaches for Boosting Secondary Metabolites in Medicinal Plant Cell Cultures.

Pooran Golkar, Edgar Vázquez-Núñez, José R Peralta-Videa

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pooran GolkarDepartment of Natural Resources, Isfahan University of Technology, Isfahan 84156-83111, Iran.ORCID 0000-0002-0547-178X
Edgar Vázquez-NúñezNano- and Biotechnological Applications for Sustainability Research Group (NanoBioTS), Division of Sciences and Engineering, Department of Chemical, Electronic and Biomedical Engineering, Laboratory for Environmental and Energy Sustainability (LaSAE), University of Guanajuato, Leon 37150, Guanajuato, Mexico.ORCID 0000-0002-5722-2718
José R Peralta-VideaDepartment of Chemistry and Biochemistry, The University of Texas at El Paso, El Paso, TX 79968, USA.ORCID 0000-0002-7424-8637

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicinal plants are a rich source of diverse secondary metabolites (SMs) with significant industrial and medicinal applications. However, the natural content of these compounds is often low and influenced by various environmental and biological factors, making large-scale extraction from conventionally cultivated plants challenging. This review comprehensively examines the efficacy and benefits of plant in vitro culture techniques, specifically, callus, cell suspension, and hairy root cultures, for enhanced SMs production. A primary focus is placed on the elicitation effects of various nanomaterials and their mechanisms of action in boosting SMs synthesis. We present successful case studies utilizing different classes of nanomaterials, including metal oxides, non-metal oxides, carbon-based materials, polysaccharides, and quantum dots, as nano-elicitors. Furthermore, the review discusses the advantages and current challenges of nanomaterial-based elicitation, as well as its future applications and prospects. The insights consolidated in this review underscore the potential of nanoparticle-mediated elicitation as a robust strategy for the efficient production of valuable SMs in plant cell cultures. Finally, we emphasize the broad utility of diverse nanomaterials and highlight critical areas requiring further investigation in this field.

Indexed as

calluscell cultureelicitorhairy rootsmetabolitesnanomaterials

Identifiers

PMID41514992
PMCPMC12788070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.